Lee Enterprises LEE Q1 2026 Earnings EPS Beats Estimates by a Wide Margin Stock Slips OCSL Q1 2026 Earnings EPS Surpasses Estimates as Portfolio Remains Resilient HTH Q1 2026 Earnings Strong EPS Beat Amid Lower Stock Reaction C4 Therapeutics Q1 2026 Earnings Strong EPS Beat Amid Continued Pipeline Progress LUCD Q1 2026 Earnings Wider Loss Than Expected as Company Navigates Operational Challenges MIRA Q3 2025 Earnings Narrowed Loss Surpasses Expectations Amid No Revenue